Although PD-L1 is overexpressed in approximately 25% of ccRCC tumors and overexpression correlates with poor prognosis, a meta-analysis by Iacovelli and colleagues suggests that its role as a predictive biomarker is unclear 40, 41. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.